Skip to main content
Figure 1 | European Journal of Medical Research

Figure 1

From: Retrospective analysis of the frequency of centrofacial telangiectasia in systemic sclerosis patients treated with bosentan or ilomedin

Figure 1

Frequency of centrofacial telangiectasia (TAE) patients with systemic sclerosis (SSc) treated with bosentan or iloprost over ten months. Patients receiving bosentan (n = 11) showed a significantly (P = 0.0028) higher frequency of centrofacial TAE (n = 41.6 ± 27.8) as compared to TAE in patients receiving iloprost (n = 16; n = 14.8 ± 13.1). Values are plotted as individual ratios, including mean ratio values shown by the horizontal bar. Data were evaluated using a Student’s t- test.

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us